Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 27% ± 5% |
Insufficient scRNA-seq data for expression of TAC1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 73% | 2970.52 | 1923 / 2642 | 74% | 14.91 | 521 / 705 |
| intestine | 71% | 364.27 | 685 / 966 | 40% | 3.78 | 209 / 527 |
| spleen | 94% | 2516.60 | 227 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 49% | 185.85 | 127 / 258 | 38% | 66.33 | 87 / 230 |
| prostate | 17% | 48.39 | 42 / 245 | 60% | 2.67 | 300 / 502 |
| thymus | 69% | 413.16 | 450 / 653 | 8% | 0.56 | 47 / 605 |
| stomach | 29% | 129.78 | 103 / 359 | 37% | 3.40 | 105 / 286 |
| breast | 31% | 91.56 | 142 / 459 | 27% | 1.23 | 306 / 1118 |
| kidney | 43% | 165.78 | 38 / 89 | 14% | 1.20 | 127 / 901 |
| pancreas | 1% | 1.95 | 4 / 328 | 41% | 3.07 | 73 / 178 |
| bladder | 5% | 8.24 | 1 / 21 | 27% | 3.01 | 135 / 504 |
| uterus | 7% | 12.99 | 12 / 170 | 19% | 4.56 | 87 / 459 |
| blood vessel | 23% | 154.80 | 301 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 13% | 44.37 | 193 / 1445 | 3% | 0.20 | 6 / 183 |
| lung | 5% | 11.72 | 27 / 578 | 10% | 6.91 | 116 / 1155 |
| adipose | 12% | 36.52 | 149 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 1% | 0.76 | 1 / 180 | 8% | 0.51 | 33 / 430 |
| skin | 4% | 6.42 | 68 / 1809 | 2% | 1.60 | 10 / 472 |
| heart | 5% | 17.66 | 46 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.07 | 3 / 80 |
| liver | 0% | 0.92 | 1 / 226 | 1% | 0.33 | 6 / 406 |
| muscle | 1% | 3.63 | 9 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0019233 | Biological process | sensory perception of pain |
| GO_0007320 | Biological process | insemination |
| GO_0007218 | Biological process | neuropeptide signaling pathway |
| GO_0048265 | Biological process | response to pain |
| GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
| GO_0006954 | Biological process | inflammatory response |
| GO_0007268 | Biological process | chemical synaptic transmission |
| GO_1990090 | Biological process | cellular response to nerve growth factor stimulus |
| GO_0009582 | Biological process | detection of abiotic stimulus |
| GO_0007267 | Biological process | cell-cell signaling |
| GO_0007217 | Biological process | tachykinin receptor signaling pathway |
| GO_0005615 | Cellular component | extracellular space |
| GO_0030424 | Cellular component | axon |
| GO_0045202 | Cellular component | synapse |
| GO_0005576 | Cellular component | extracellular region |
| GO_0043025 | Cellular component | neuronal cell body |
| GO_0031835 | Molecular function | substance P receptor binding |
| Gene name | TAC1 |
| Protein name | Protachykinin-1 (PPT) [Cleaved into: Substance P; Neurokinin A (NKA) (Neuromedin L) (Substance K); Neuropeptide K (NPK); Neuropeptide gamma; C-terminal-flanking peptide] |
| Synonyms | TAC2 NKNA NKA |
| Description | FUNCTION: Tachykinins are active peptides which excite neurons, evoke behavioral responses, are potent vasodilators and secretagogues, and contract (directly or indirectly) many smooth muscles. |
| Accessions | ENST00000346867.4 [P20366-3] ENST00000350485.8 [P20366-2] ENST00000319273.10 [P20366-1] P20366 |